Johnson & Johnson continues to be targeted by plaintiffs claiming that use of the company’s talcum powder products can contribute to ovarian cancer. Court records indicate that 10 of the most recent cases were filed on a single day last … Continue reading
The pharmaceutical industry has urged U.S. health regulators to loosen rules that govern the off-label promotion of prescription drugs. These types of marketing practices are among the major issues of contention central to thousands of Risperdal lawsuits and Zofran birth … Continue reading
Two additional studies have suggested that proton pump inhibitors like Nexium could have unintended health consequences. These new findings follow earlier research that has tied the popular heartburn medications to a number of serious side effects, including kidney failure and … Continue reading
GlaxoSmithKline, the primary defendant in hundreds of Zofran birth defects lawsuits, is seeking to have more than two dozen federal cases dismissed that involve the drug’s generic equivalents. The company has also asked to have all fraud claims tossed from … Continue reading
Plaintiff’s pursuing federal hernia mesh lawsuits involving Atrium’s C-Qur product line have asked the U.S. Judicial Panel on Multidistrict Litigation (JPML) to centralize all federally-filed claims in a single jurisdiction. Court records indicate that the Panel will hear Oral Arguments … Continue reading
The federal court tapped to oversee what could eventually be hundreds of Abilify gambling lawsuits convened its Initial Conference on November 7th. An Order filed in the U.S. District Court, Northern District of Florida, on October 19th indicated that a … Continue reading
The manufacturer of a Heater-Cooler device used during cardiothoracic surgery has been hit with a lawsuit following the death of an Iowa man from a fatal M. Chimaera infection. The complaint, which is currently pending in the U.S. District Court, … Continue reading
Nexium sales could be adversely affected by a growing number of lawsuits involving the drug’s alleged kidney side effects. The litigation, coupled with mounting concerns about the safety of proton pump inhibitors in general, could ultimately cause doctors to reconsider … Continue reading
Abcodia, Inc. has suspended sales of its Risk of Ovarian Cancer Algorithm (ROCA) test in response to a recent Food & Drug Administration (FDA) warning against the use of such products. According to the FDA, ovarian cancer tests like ROCA … Continue reading
St. Jude Medical has asked doctors to stop implanting its Nanostim leadless cardiac pacemaker (LCP) due to problems with electronic data reporting caused by a battery malfunction. Though no injuries have been tied to the Nanostim problem, the company is … Continue reading